Page last updated: 2024-11-05
dihydrocarvone
Description
Dihydrocarvone is a bicyclic monoterpene ketone that exists in two enantiomeric forms: (-)-dihydrocarvone and (+)-dihydrocarvone. It is a colorless liquid with a characteristic camphoraceous odor. Dihydrocarvone is a common constituent of essential oils derived from plants such as caraway, dill, and spearmint. It can be synthesized through the catalytic hydrogenation of carvone, a naturally occurring monoterpene ketone. Dihydrocarvone exhibits various biological activities, including anti-inflammatory, antimicrobial, and antioxidant effects. It has also been found to possess insecticidal properties and is used in the formulation of insect repellents. The study of dihydrocarvone is of interest due to its potential applications in various industries, including pharmaceuticals, cosmetics, and food additives. Its unique chemical structure and biological activities make it a promising candidate for the development of new therapeutic agents and bioactive compounds.'
dihydrocarvone: found in caraway oil; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
dihydrocarvone : A dihydrocarvone resulting from reduction of the endocyclic cyclohexene double bond. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 24473 |
CHEBI ID | 23733 |
SCHEMBL ID | 309206 |
MeSH ID | M0555999 |
Synonyms (42)
Synonym |
LS-13847 |
p-menth-8-en-2-one |
cyclohexanone, 2-methyl-5-(1-methylethenyl)- |
dihydrocarvone |
8-p-menthen-2-one |
p-menth-8(9)-en-2-one |
2-methyl-5-(1-methylethenyl)cyclohexanone |
2-methyl-5-(1-methylvinyl)cyclohexan-1-one |
einecs 231-857-0 |
CHEBI:23733 |
7764-50-3 |
2-methyl-5-(prop-1-en-2-yl)cyclohexanone |
menth-8-en-2-one |
2-methyl-5-isopropenylcyclohexanone |
5-isopropenyl-2-methylcyclohexanone |
2-methyl-5-prop-1-en-2-ylcyclohexan-1-one |
C18018 |
2-methyl-5-(prop-1-en-2-yl)cyclohexan-1-one |
unii-yqs5cw1o1j |
3-isopropenyl-6-methylcyclohexanone |
yqs5cw1o1j , |
dihydrocarvone, (+)- |
FT-0624469 |
AKOS015907251 |
SCHEMBL309206 |
AZOCECCLWFDTAP-UHFFFAOYSA-N |
5-isopropenyl-2-methylcyclohexanone # |
W-104306 |
1,6-dihydrocarvone |
cyclohexanone,2-methyl-5-(1-methylethenyl)- |
mfcd00001636 |
2-methyl-5-(1-methylethenyl)-cyclohexanone |
2-methyl-5-(1-methylethenyl)cyclohexanone, 9ci |
fema 3565 |
FT-0773968 |
DTXSID00863556 |
E76541 |
Q27109809 |
BCP30885 |
a dihydrocarvone |
an isodihydrocarvone |
CS-0031698 |
Roles (1)
Role | Description |
plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
Class | Description |
dihydrocarvones | Any carvone having one of its C=C double bonds reduced. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (15)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 10 (66.67) | 24.3611 |
2020's | 5 (33.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 32.89
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 32.89 (24.57) | Research Supply Index | 2.77 (2.92) | Research Growth Index | 4.62 (4.65) | Search Engine Demand Index | 42.09 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (13.33%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (86.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |